What is Xeris Biopharma Holdings, Inc.'s net change in cash?

Xeris Biopharma Holdings, Inc. (XERS) reported net change in cash of $708K in Q1 2026.

How has Xeris Biopharma Holdings, Inc.'s net change in cash changed year-over-year?

Xeris Biopharma Holdings, Inc.'s net change in cash increased by 105.4% year-over-year, from -$13.18M to $708K.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Xeris Biopharma Holdings, Inc. XERS Net Change in Cash

Net Change in Cash at other companies

Eli LillyLLY

-$1.99B-1,035%

Corcept TherapeuticsCORT

-$11.76M+68.9%

Eton Pharmaceuticals, Inc.ETON

-$6.28M-353%

Ultragenyx PharmaceuticalRARE

-$247M-449%

Zevra Therapeutics, Inc.ZVRA

$33.19M+834%

ANI PharmaceuticalsANIP

$25.59M+418%

Other financials

Income statement

See full

Revenue$83.1M+38.3%

Gross profit$72.6M+41.2%

Operating income$7.9M+356%

Net income$2.2M+124%

EPS (diluted)$0.01+117%

Balance sheet

See full

Cash & equivalents$111.8M+91.2%

Total debt$258.6M-3.8%

Total equity$13.0M+137%

Total assets$392.0M+24.3%

Cash flow

See full

Operating cash flow$9.9M+198%

CapEx$131.0K—

Free cash flow-$29.1M—

Valuation

See full

Market cap$1.28B+76.9%

Enterprise value$1.42B+52.7%

P/E106.4×—

P/S4.1×+0.8×

Profitability

See full

Gross margin85.9%+3.7pp

Operating margin11.4%+7.7pp

Net margin3.8%+2.1pp

Returns & leverage

See full

Return on equity-209.8%—

Debt / equity19.9×—

Current ratio2.1×+0.4×

Where this comes from

Reported directly by Xeris Biopharma Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xeris Biopharma Holdings, Inc.'s net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Xeris Biopharma Holdings, Inc.'s net change in cash?: Xeris Biopharma Holdings, Inc. (XERS) reported net change in cash of $708K in Q1 2026.
How has Xeris Biopharma Holdings, Inc.'s net change in cash changed year-over-year?: Xeris Biopharma Holdings, Inc.'s net change in cash increased by 105.4% year-over-year, from -$13.18M to $708K.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.